Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × trifluridine tipiracil drug combination × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 27 Rectal Neoplasms 7 Colonic Neoplasms 7 Stomach Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Advanced Solid Tumors 3 Pancreatic Neoplasms 2 Neutropenia 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 mCRC 1 Spinocerebellar Degenerations 1 Solid Tumor Cancer 1 Prostatic Neoplasms 1 Microsatellite-stable Colorectal Cancer 1 Metastatic Gastric Adenocarcinoma 1 Lung Neoplasms 1 High-grade Extra Pulmonary Neuroendocrine Cancer 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 ESCC 1 EFS 1

Interventions

Cyclophosphamide 6 Vincristine 3 Temozolomide 3 Radiotherapy 3 Cisplatin 3 Automobiles 3 fludarabine 2 Etoposide 2 Eflornithine 2 Carboplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 belzutifan 1 Zoledronic Acid 1 Thiotepa 1 Tamoxifen 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Mesna 1 Maintenance Chemotherapy 1 Lomustine 1 Isotretinoin 1 Infusions, Intravenous 1 Induction Chemotherapy 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡